Bristol Myers Squibb (BMY) EBT Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
156.08% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-56.06% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-37.45% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-159.29% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
5.63% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
56.46% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
13.82% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
9.05% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
9.05% |
| Dec 31, 2025 |
740.00% |
| Sep 30, 2025 |
85.80% |
| Jun 30, 2025 |
37.87% |
| Mar 31, 2025 |
125.80% |
| Dec 31, 2024 |
-89.55% |
| Sep 30, 2024 |
-21.57% |
| Jun 30, 2024 |
-30.82% |
| Mar 31, 2024 |
-515.74% |
| Dec 31, 2023 |
-9.95% |
| Sep 30, 2023 |
-3.26% |
| Jun 30, 2023 |
-5.06% |
| Mar 31, 2023 |
64.20% |
| Dec 31, 2022 |
0.05% |
| Sep 30, 2022 |
2.41% |
| Jun 30, 2022 |
26.08% |
| Mar 31, 2022 |
-33.32% |
| Dec 31, 2021 |
117.78% |
| Sep 30, 2021 |
-4.43% |
| Jun 30, 2021 |
-4.55% |
| Mar 31, 2021 |
932.24% |
| Dec 31, 2020 |
-8,001.55% |
| Sep 30, 2020 |
67.31% |
| Jun 30, 2020 |
-8.39% |
| Mar 31, 2020 |
-115.36% |
| Dec 31, 2019 |
-108.57% |
| Sep 30, 2019 |
-37.75% |
| Jun 30, 2019 |
243.52% |
| Mar 31, 2019 |
11.24% |
| Dec 31, 2018 |
115.62% |
| Sep 30, 2018 |
83.18% |
| Jun 30, 2018 |
-60.08% |
| Mar 31, 2018 |
-9.00% |
| Dec 31, 2017 |
-35.73% |
| Sep 30, 2017 |
-24.12% |
| Jun 30, 2017 |
-19.81% |
| Mar 31, 2017 |
18.13% |
| Dec 31, 2016 |
364.88% |
| Sep 30, 2016 |
57.95% |
| Jun 30, 2016 |
3,005.77% |
| Mar 31, 2016 |
14.30% |
| Dec 31, 2015 |
-583.33% |
| Sep 30, 2015 |
-2.08% |
| Jun 30, 2015 |
-88.39% |
| Mar 31, 2015 |
47.01% |
| Dec 31, 2014 |
-106.90% |
| Sep 30, 2014 |
23.23% |
| Jun 30, 2014 |
-15.47% |
| Mar 31, 2014 |
46.14% |
| Dec 31, 2013 |
69.40% |
| Sep 30, 2013 |
164.97% |
| Jun 30, 2013 |
-49.95% |
| Mar 31, 2013 |
-66.75% |
| Dec 31, 2012 |
-67.82% |
| Sep 30, 2012 |
-168.80% |
| Jun 30, 2012 |
-40.84% |
| Mar 31, 2012 |
14.71% |
| Dec 31, 2011 |
293.21% |
| Sep 30, 2011 |
13.38% |
| Jun 30, 2011 |
12.44% |
| Mar 31, 2011 |
21.69% |
| Dec 31, 2010 |
-162.50% |
| Sep 30, 2010 |
3.13% |
| Jun 30, 2010 |
4.60% |
| Mar 31, 2010 |
21.51% |
